JP2018109068A5 - - Google Patents

Download PDF

Info

Publication number
JP2018109068A5
JP2018109068A5 JP2018076529A JP2018076529A JP2018109068A5 JP 2018109068 A5 JP2018109068 A5 JP 2018109068A5 JP 2018076529 A JP2018076529 A JP 2018076529A JP 2018076529 A JP2018076529 A JP 2018076529A JP 2018109068 A5 JP2018109068 A5 JP 2018109068A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
halogen
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018076529A
Other languages
English (en)
Japanese (ja)
Other versions
JP6561167B2 (ja
JP2018109068A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018109068A publication Critical patent/JP2018109068A/ja
Publication of JP2018109068A5 publication Critical patent/JP2018109068A5/ja
Application granted granted Critical
Publication of JP6561167B2 publication Critical patent/JP6561167B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018076529A 2013-12-12 2018-04-12 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物 Expired - Fee Related JP6561167B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130154455 2013-12-12
KR10-2013-0154455 2013-12-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016539198A Division JP2016540024A (ja) 2013-12-12 2014-12-12 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物

Publications (3)

Publication Number Publication Date
JP2018109068A JP2018109068A (ja) 2018-07-12
JP2018109068A5 true JP2018109068A5 (cg-RX-API-DMAC7.html) 2018-10-11
JP6561167B2 JP6561167B2 (ja) 2019-08-14

Family

ID=53370682

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016539198A Pending JP2016540024A (ja) 2013-12-12 2014-12-12 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物
JP2018076529A Expired - Fee Related JP6561167B2 (ja) 2013-12-12 2018-04-12 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016539198A Pending JP2016540024A (ja) 2013-12-12 2014-12-12 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物

Country Status (12)

Country Link
US (1) US9650379B2 (cg-RX-API-DMAC7.html)
EP (1) EP3080125B1 (cg-RX-API-DMAC7.html)
JP (2) JP2016540024A (cg-RX-API-DMAC7.html)
KR (1) KR101689394B1 (cg-RX-API-DMAC7.html)
CN (1) CN105940001B (cg-RX-API-DMAC7.html)
DK (1) DK3080125T3 (cg-RX-API-DMAC7.html)
ES (1) ES2704704T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181965T1 (cg-RX-API-DMAC7.html)
PL (1) PL3080125T3 (cg-RX-API-DMAC7.html)
PT (1) PT3080125T (cg-RX-API-DMAC7.html)
TR (1) TR201900057T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015087151A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015157504A1 (en) 2014-04-11 2015-10-15 Taipei Medical University Histone deacetylase inhibitors
NZ739211A (en) 2015-07-27 2019-05-31 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same
BR112017027798B1 (pt) 2015-07-27 2023-12-19 Chong Kun Dang Pharmaceutical Corp Compostos de derivado de 1,3,4-oxadiazol sulfamida como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos
HRP20230052T1 (hr) 2015-07-27 2023-03-03 Chong Kun Dang Pharmaceutical Corp. Spojevi derivata 1,3,4-oksadiazol sulfonamida kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
HRP20220003T1 (hr) 2015-08-04 2022-04-01 Chong Kun Dang Pharmaceutical Corp. Spojevi derivata 1,3,4-oksadiazola kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
FI3362445T3 (fi) 2015-10-12 2023-03-21 Chong Kun Dang Pharmaceutical Corp Oksadiatsoliamiinijohdannaisyhdisteitä histonideasetylaasi 6:n inhibiittoreina ja niitä käsittävä farmaseuttinen koostumus
WO2017161028A1 (en) 2016-03-16 2017-09-21 Kura Oncology, Inc. Substituted inhibitors of menin-mll and methods of use
KR102002581B1 (ko) * 2016-10-04 2019-07-22 주식회사 종근당 혈액암 치료를 위한 hdac 저해제 및 프로테아좀 억제제 또는 면역조절성 약물을 포함하는 약학적 조합물
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
IT201700041723A1 (it) 2017-04-14 2018-10-14 Italfarmaco Spa Nuovi inibitori selettivi di HDAC6
TW201920170A (zh) * 2017-09-20 2019-06-01 美商庫拉腫瘤技術股份有限公司 經取代之menin-mll 抑制劑及使用方法
KR102236356B1 (ko) 2017-11-24 2021-04-05 주식회사 종근당 루푸스의 예방 또는 치료를 위한 조성물
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
KR20200041812A (ko) * 2018-10-12 2020-04-22 주식회사 종근당 히스톤 탈아세틸화 효소 억제제 및 메토트렉세이트를 포함하는 약학적 조성물
CN113874369B (zh) 2019-05-31 2024-08-27 株式会社钟根堂 作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑高邻苯二甲酰亚胺衍生化合物及包含其的药物组合物
CN115443329A (zh) 2019-06-27 2022-12-06 乔治华盛顿大学国会特许非营利公司 Hdac6激活的巨噬细胞、其组合物及用途
CN114727974A (zh) 2019-07-30 2022-07-08 艾科尼佐治疗股份有限公司 Hdac6抑制剂及其用途
TWI908740B (zh) * 2019-10-09 2025-12-21 美商百歐克斯製藥公司 口服補體因子d抑制劑
WO2022169985A1 (en) 2021-02-03 2022-08-11 Eikonizo Therapeutics, Inc. Hdac6 inhibitors and uses thereof
AU2023250964A1 (en) 2022-04-08 2024-11-07 Eikonizo Therapeutics, Inc. Oxadiazole hdac6 inhibitors and uses thereof
CN115417877B (zh) * 2022-09-20 2024-05-14 杭州师范大学 组蛋白去乙酰化酶抑制剂及其制备和在制备抗癌症药物上的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38506E1 (en) 1991-10-04 2004-04-20 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US6174905B1 (en) 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
EP2292593A3 (en) 2000-09-29 2011-05-25 TopoTarget UK Limited Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
BRPI0817897A2 (pt) * 2007-11-02 2019-09-24 Methylgene Inc composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac
MX2010006243A (es) * 2007-12-06 2010-08-31 Schering Corp Moduladores de gamma secretasa.
KR101168801B1 (ko) 2009-03-27 2012-07-25 주식회사종근당 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물
JP5838157B2 (ja) 2009-07-22 2015-12-24 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイThe Board Of Trustees Of The University Of Illinois Hdac阻害剤およびそれを用いる治療法
USRE47009E1 (en) * 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
WO2012178208A2 (en) * 2011-06-24 2012-12-27 The Trustees Of The Stevens Institute Of Technology Selective inhibitors of histone deacetylase isoform 6 and methods thereof
WO2013052110A1 (en) * 2011-10-03 2013-04-11 The Trustees Of Columbia University In The City Of New York Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
WO2013062344A1 (en) * 2011-10-28 2013-05-02 Chong Kun Dang Pharmaceutical Corp. Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
EP2785720B1 (en) 2011-11-29 2017-08-09 Nanjing Allgen Pharma Co. Ltd. Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents

Similar Documents

Publication Publication Date Title
JP2021516237A5 (cg-RX-API-DMAC7.html)
JP2018531218A5 (cg-RX-API-DMAC7.html)
JP2020500178A5 (cg-RX-API-DMAC7.html)
JP2005517675A5 (cg-RX-API-DMAC7.html)
EP4473980A3 (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers
JP2019513770A5 (cg-RX-API-DMAC7.html)
JP2020519664A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2014508753A5 (cg-RX-API-DMAC7.html)
JP2015524457A5 (cg-RX-API-DMAC7.html)
JP2015523385A5 (cg-RX-API-DMAC7.html)
JP2017517538A5 (cg-RX-API-DMAC7.html)
JP2017509586A5 (cg-RX-API-DMAC7.html)
JP2007504171A5 (cg-RX-API-DMAC7.html)
JP2017536395A5 (cg-RX-API-DMAC7.html)
JP2018135343A5 (cg-RX-API-DMAC7.html)
JP2008510828A5 (cg-RX-API-DMAC7.html)
JP2010527913A5 (cg-RX-API-DMAC7.html)
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2015143283A5 (cg-RX-API-DMAC7.html)
JP2012528839A5 (cg-RX-API-DMAC7.html)
JP2017525699A5 (cg-RX-API-DMAC7.html)
JP2015512883A5 (cg-RX-API-DMAC7.html)
JP2018500287A5 (cg-RX-API-DMAC7.html)
JP2021513547A5 (cg-RX-API-DMAC7.html)